These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19623030)

  • 1. Antibody-mediated rejection of the pancreas allograft.
    Torrealba JR; Odorico J
    Transplantation; 2009 Jul; 88(2):292-3. PubMed ID: 19623030
    [No Abstract]   [Full Text] [Related]  

  • 2. Simultaneous antibody-mediated rejection of multiple allografts in modified multivisceral transplantation.
    Takahashi H; Kato T; Mizutani K; Terasaki P; Delacruz V; Tzakis AG; Ruiz P
    Clin Transpl; 2006; ():529-34. PubMed ID: 18365419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dimensions of antibody-mediated rejection.
    Colvin RB
    Am J Transplant; 2010 Jul; 10(7):1509-10. PubMed ID: 20642676
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibody-mediated organ-allograft rejection.
    Colvin RB; Smith RN
    Nat Rev Immunol; 2005 Oct; 5(10):807-17. PubMed ID: 16175181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The usefulness of hyperimmune globulin for treatment of overt cytomegalovirus infection in allograft recipients.
    Rancewicz Z; Halama G; Smogorzewski M; Durlik M; Rowinska D; Lao M; Juskowa J; Wyzgal J
    Transplant Proc; 1990 Aug; 22(4):1818-9. PubMed ID: 2167538
    [No Abstract]   [Full Text] [Related]  

  • 6. C4d-positive interacinar capillaries correlates with donor-specific antibody-mediated rejection in pancreas allografts.
    Torrealba JR; Samaniego M; Pascual J; Becker Y; Pirsch J; Sollinger H; Odorico J
    Transplantation; 2008 Dec; 86(12):1849-56. PubMed ID: 19104433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific humoral rejection of a pancreas allograft in a recipient of pancreas after kidney transplantation.
    Carbajal R; Karam G; Renaudin K; Maillet F; Cesbron A; Rostaing L; Cantarovich D; Soulillou JP; Blancho G
    Nephrol Dial Transplant; 2007 Mar; 22(3):942-4. PubMed ID: 17210592
    [No Abstract]   [Full Text] [Related]  

  • 8. Importance of donor-reactive cytotoxic antibodies following cardiac transplantation.
    Smith JD; Morgan AJ; Bravery C; Rose ML; Sachs JA; Yacoub MH
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1133-4. PubMed ID: 1989168
    [No Abstract]   [Full Text] [Related]  

  • 9. Controversies in defining cardiac antibody-mediated rejection: need for updated criteria.
    Kfoury AG; Hammond ME
    J Heart Lung Transplant; 2010 Apr; 29(4):389-94. PubMed ID: 20189413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-mediated rejection of the lung: A consensus report of the International Society for Heart and Lung Transplantation.
    Levine DJ; Glanville AR; Aboyoun C; Belperio J; Benden C; Berry GJ; Hachem R; Hayes D; Neil D; Reinsmoen NL; Snyder LD; Sweet S; Tyan D; Verleden G; Westall G; Yusen RD; Zamora M; Zeevi A
    J Heart Lung Transplant; 2016 Apr; 35(4):397-406. PubMed ID: 27044531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indirect allorecognition in heart allograft rejection.
    Ciubotariu R; Liu Z; Ho E; Vasilescu R; Foca-Rodi A; Colovai AI; Fisher P; Hardy M; Rose EA; Cortesini R; Suciu Foca Cortesini N
    Transplant Proc; 2001; 33(1-2):1612. PubMed ID: 11267441
    [No Abstract]   [Full Text] [Related]  

  • 12. Alloantibodies restore cardiac allograft rejection to IgKO mice.
    Wasowska BA; Qian Z; Cangello DL; Van Tran K; Layton JL; Sanfilippo F; Baldwin WM
    Transplant Proc; 2001; 33(1-2):317. PubMed ID: 11266837
    [No Abstract]   [Full Text] [Related]  

  • 13. Alloantibodies and outcomes of deceased donor kidney allografts.
    Cinti P; Pretagostini R; Lai Q; Tamburro ML; Rossi M; Poli L; Berloco P
    Hum Immunol; 2009 Aug; 70(8):651-4. PubMed ID: 19527761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interacinar c4d staining in pancreas allografts.
    Munivenkatappa RB; Philosophe B; Papadimitriou JC; Drachenberg CB
    Transplantation; 2009 Jul; 88(1):145-6. PubMed ID: 19584698
    [No Abstract]   [Full Text] [Related]  

  • 15. Alloantibody-associated chronic rejection of MHC class I-disparate heart grafts is modulated by intravenous soluble donor alloantigen.
    Easterfield AJ; Delriviere L; Wallduck MS; Sivaganesh S; Bradley JA; Bolton EM
    Transpl Immunol; 2007 Nov; 18(2):138-41. PubMed ID: 18005858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donor-specific antibody detection for diagnosis of antibody-mediated rejection in kidney transplantation.
    Gautreau C; Suberbielle C; Andrade J; Charron D
    Clin Transpl; 2006; ():502. PubMed ID: 18365411
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibody-mediated rejection in the kidney.
    Racusen LC
    Transplant Proc; 2004 Apr; 36(3):768-9. PubMed ID: 15110657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospects and limitations of post-transplantation alloantibody detection in renal transplantation.
    Böhmig GA; Bartel G; Regele H; Wahrmann M
    Hum Immunol; 2009 Aug; 70(8):640-4. PubMed ID: 19375475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms involved in antibody- and complement-mediated allograft rejection.
    Wasowska BA
    Immunol Res; 2010 Jul; 47(1-3):25-44. PubMed ID: 20135240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are De Novo DQ Donor-Specific Antibodies the Key to Chronic Lung Allograft Dysfunction?
    Shenoy KV
    Am J Respir Crit Care Med; 2016 Sep; 194(5):534-5. PubMed ID: 27585379
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.